WALDENSTROM MACROGLOBULINEMIA
Clinical trials for WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smarter CMV strategy may protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study tested a modified approach to prevent and manage cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV treatment could still keep patients safe while reducing unneces…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 02:40 UTC
-
Promising combo tackles nerve pain in rare blood cancers
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab can safely reduce nerve damage symptoms in people with IgM MGUS or Waldenstrom macroglobulinemia. The goal is to lower abnormal IgM protein levels that attack nerves. Twelve adults with confirmed IgM-related neuropat…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
Scientists hunt for hidden genes behind family blood cancers
Knowledge-focused OngoingThis study looks at people and families who may have a higher chance of getting blood or lymph node cancers, like leukemia or lymphoma. Researchers want to learn what causes these cancers by studying genes, environment, and medical history. Participants fill out questionnaires, g…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:39 UTC